Revenue | $10 - $100 million See Exact Annual Revenue |
---|---|
Employees | 100 - 500Exact Company Size |
Primary Industry | 621511 Medical Laboratories |
Address | Suite 100 2970, Wilderness Place Boulder, CO 80301 |
Biodesix | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | $10 - $100 million Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): |
Biodesix P&L | $ Millions |
---|---|
Revenue (Sales) | |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
IQLUNG medical diagnostic testing and reporting services ordered by health care providers to provide them with information for disease detection, diagnosis, or treatment | 11/12/2021 |
GENESTRAT NGS Medical testing services relating to the diagnosis and treatment of disease for assessing the likelihood of patient outcomes and medical treatments | 09/20/2021 |
SIMPLESEP Medical devices, namely, a blood container for medical purposes specially designed for the separation of blood components and transportation of blood, sold empty | 08/09/2021 |
Date | Event |
---|---|
Jun 12, 2017 | Biodesix® and Positive Bioscience Announce Partnership to Bring Cancer Tests to India |
May 22, 2017 | New Study Shows Advanced Diagnostic Tests, Including the VeriStrat® Test, Can Help Physicians Improve Cancer Care Planning and Reach Quality Measures For Patients |
Apr 05, 2017 | Biodesix Presents Data From Three Studies at AACR Annual Meeting |
Apr 03, 2017 | New Data Show Biodesix’s VeriStrat® Test is Cost-Saving, Improves Survival and Quality of Life in Advanced Lung-Cancer Patients |
Mar 22, 2017 | New Study Shows Biodesix’s VeriStrat Changes Treatment Decisions for Lung Cancer Patients; Reduces Over-Treatment at End of Life |
Mar 20, 2017 | Study Results from Biodesix’s Immunotherapy Test Will Be Presented by Dr. Jeffrey Weber |
Mar 09, 2017 | Biodesix® and Progenetics Announce Distribution Agreement for Israel |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
PHYSICIANS IMMUNODIAGNOSTIC LABORATORY | Burbank, CA | 100 |
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY | Linden, NJ | 100 |
CENTOGENE US | Cambridge, MA | 88 |
LATARA ENTERPRISE | Pomona, CA | 61 |
TELIGENT PHARMA | Vineland, NJ | 46 |
COVID CLINIC | Huntington Beach, CA | 37 |
VIKOR SCIENTIFIC | Charleston, SC | 33 |
BIOTHERANOSTICS | San Diego, CA | 31 |
SHERMAN-ABRAMS LABORATORY | Brooklyn, NY | 31 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
BIODESIX | Boulder, CO | 100 |
PANTHERYX | Boulder, CO | 84 |
ALPHA CATALYST GENOMICS | Boulder, CO | 60 |
RM3 LABS COLORADO | Boulder, CO | 20 |
Company | Revenue ($ MM) |
---|---|
|